Abbvie (ABBV) PT Lowered to $79 at Credit Suisse
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $252.57 -0.31%
Rating Summary:
26 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 23 | New: 95
Rating Summary:
26 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 23 | New: 95
Join SI Premium – FREE
Credit Suisse analyst Vamil Divan lowered the price target on Abbvie (NYSE: ABBV) to $79.00 (from $85.00) while maintaining a Underperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
- AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
- Paylocity Holding (PCTY) PT Lowered to $165 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
